These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12873982)

  • 1. Reactivation of mutant p53 by a one-hybrid adaptor protein.
    Roth J; Lenz-Bauer C; Contente A; Löhr K; Koch P; Bernard S; Dobbelstein M
    Cancer Res; 2003 Jul; 63(14):3904-8. PubMed ID: 12873982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
    Di Como CJ; Gaiddon C; Prives C
    Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of cellular and viral promoters by p73 and p53.
    Deb D; Lanyi A; Scian M; Keiger J; Brown DR; Le Roith D; Deb SP; Deb S
    Int J Oncol; 2001 Feb; 18(2):401-9. PubMed ID: 11172610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
    Kim EJ; Park JS; Um SJ
    J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of p73 and p53 regulation and effector functions.
    Fang L; Lee SW; Aaronson SA
    J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.
    Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M
    Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
    Roth J; Koch P; Contente A; Dobbelstein M
    Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the p53-homologue p73 in E2F1-induced apoptosis.
    Stiewe T; Pützer BM
    Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 transcriptional activity increases upon cooperation between its spliced forms.
    Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
    Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and functional interaction between p53 mutants and different isoforms of p73.
    Strano S; Munarriz E; Rossi M; Cristofanelli B; Shaul Y; Castagnoli L; Levine AJ; Sacchi A; Cesareni G; Oren M; Blandino G
    J Biol Chem; 2000 Sep; 275(38):29503-12. PubMed ID: 10884390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73.
    Higashino F; Pipas JM; Shenk T
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15683-7. PubMed ID: 9861030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
    Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
    Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor.
    Jung MS; Yun J; Chae HD; Kim JM; Kim SC; Choi TS; Shin DY
    Oncogene; 2001 Sep; 20(41):5818-25. PubMed ID: 11593387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The large T antigen of simian virus 40 binds and inactivates p53 but not p73.
    Dobbelstein M; Roth J
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():3079-83. PubMed ID: 9880025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
    Vikhanskaya F; D'Incalci M; Broggini M
    Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
    Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.